Targeting SARS-CoV-2 Receptor Binding Domain with Stapled Peptides: An In Silico StudyClick to copy article linkArticle link copied!
- Luana Janaína de CamposLuana Janaína de CamposDepartment of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United StatesMore by Luana Janaína de Campos
- Nicholas Y. PalermoNicholas Y. PalermoComputational Chemistry Core Facility, Vice Chancellor for Research Cores, University of Nebraska Medical Center, Omaha, Nebraska 68198, United StatesMore by Nicholas Y. Palermo
- Martin Conda-Sheridan*Martin Conda-Sheridan*Email: [email protected]. Phone: +1-402-559-9361.Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska 68198, United StatesMore by Martin Conda-Sheridan
Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has evolved into a pandemic of unprecedented scale. This coronavirus enters cells by the interaction of the receptor binding domain (RBD) with the human angiotensin-converting enzyme 2 receptor (hACE2). In this study, we employed a rational structure-based design to propose 22-mer stapled peptides using the structure of the hACE2 α1 helix as a template. These peptides were designed to retain the α-helical character of the natural structure, to enhance binding affinity, and to display a better solubility profile compared to other designed peptides available in the literature. We employed different docking strategies (PATCHDOCK and ZDOCK) followed by a double-step refinement process (FIBERDOCK) to rank our peptides, followed by stability analysis/evaluation of the interaction profile of the best docking predictions using a 500 ns molecular dynamics (MD) simulation, and a further binding affinity analysis by molecular mechanics with generalized Born and surface area (MM/GBSA) method. Our most promising stapled peptides presented a stable profile and could retain important interactions with the RBD in the presence of the E484K RBD mutation. We predict that these peptides can bind to the viral RBD with similar potency to the control NYBSP-4 (a 30-mer experimentally proven peptide inhibitor). Furthermore, our study provides valuable information for the rational design of double-stapled peptide as inhibitors of SARS-CoV-2 infection.
Cited By
Smart citations by scite.ai include citation statements extracted from the full text of the citing article. The number of the statements may be higher than the number of citations provided by ACS Publications if one paper cites another multiple times or lower if scite has not yet processed some of the citing articles.
This article is cited by 15 publications.
- Nikhil Maroli. Riding the Wave: Unveiling the Conformational Waves from RBD of SARS-CoV-2 Spike Protein to ACE2. The Journal of Physical Chemistry B 2023, 127
(40)
, 8525-8536. https://doi.org/10.1021/acs.jpcb.3c04366
- Aditya K. Padhi, Soumya Lipsa Rath, Timir Tripathi. Accelerating COVID-19 Research Using Molecular Dynamics Simulation. The Journal of Physical Chemistry B 2021, 125
(32)
, 9078-9091. https://doi.org/10.1021/acs.jpcb.1c04556
- James H. Zothantluanga, Abd. Kakhar Umar, Keerthic Aswin, Sanchaita Rajkhowa, Dipak Chetia. Revelation of potential drug targets of luteolin in
Plasmodium falciparum
through multi-target molecular dynamics simulation studies. Journal of Biomolecular Structure and Dynamics 2024, 42
(21)
, 11612-11628. https://doi.org/10.1080/07391102.2023.2263875
- Sicheng Jiang, Yu Tian, Vlad Nicolaescu, Aslan Mansurov, Glenn Randall, Matthew V. Tirrell, James L. LaBelle. The Role of Structural Flexibility in Hydrocarbon‐Stapled Peptides Designed to Block Viral Infection via Human
ACE2
Mimicry. Peptide Science 2024, 116
(6)
https://doi.org/10.1002/pep2.24375
- Muhammad Tariq Zeb, Elise Dumont, Muhammad Tahir Khan, Aroosa Shehzadi, Irshad Ahmad. Multi-Epitopic Peptide Vaccine Against Newcastle Disease Virus: Molecular Dynamics Simulation and Experimental Validation. Vaccines 2024, 12
(11)
, 1250. https://doi.org/10.3390/vaccines12111250
- Qian Zhang, Ziyang Wang, Xiaohan Mei, Quan Chen, Chunqiu Zhang. Stapled peptides: targeting protein-protein interactions in drug development. Exploration of Drug Science 2024, , 154-189. https://doi.org/10.37349/eds.2024.00041
- Giacomo Parisi, Roberta Piacentini, Alessio Incocciati, Alessandra Bonamore, Alberto Macone, Jakob Rupert, Elsa Zacco, Mattia Miotto, Edoardo Milanetti, Gian Gaetano Tartaglia, Giancarlo Ruocco, Alberto Boffi, Lorenzo Di Rienzo. Design of protein-binding peptides with controlled binding affinity: the case of SARS-CoV-2 receptor binding domain and angiotensin-converting enzyme 2 derived peptides. Frontiers in Molecular Biosciences 2024, 10 https://doi.org/10.3389/fmolb.2023.1332359
- Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, Rene B. Khan, Hezekiel M. Kumalo. Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors. International Journal of Molecular Sciences 2023, 24
(21)
, 15518. https://doi.org/10.3390/ijms242115518
- Ana Laura Pereira Lourenço, Thuanny Borba Rios, Állan Pires da Silva, Octávio Luiz Franco, Marcelo Henrique Soller Ramada. Peptide Stapling Applied to Antimicrobial Peptides. Antibiotics 2023, 12
(9)
, 1400. https://doi.org/10.3390/antibiotics12091400
- Waseem Ahmad Ansari, Safia Obaidur Rab, Mohammad Saquib, Aqib Sarfraz, Mohd Kamil Hussain, Mohd Sayeed Akhtar, Irfan Ahmad, Mohammad Faheem Khan. Pentafuhalol-B, a Phlorotannin from Brown Algae, Strongly Inhibits the PLK-1 Overexpression in Cancer Cells as Revealed by Computational Analysis. Molecules 2023, 28
(15)
, 5853. https://doi.org/10.3390/molecules28155853
- Roxana-Maria Amărandi, Maria-Cristina Al-Matarneh, Lăcrămioara Popovici, Catalina Ionica Ciobanu, Andrei Neamțu, Ionel I. Mangalagiu, Ramona Danac. Exploring Pyrrolo-Fused Heterocycles as Promising Anticancer Agents: An Integrated Synthetic, Biological, and Computational Approach. Pharmaceuticals 2023, 16
(6)
, 865. https://doi.org/10.3390/ph16060865
- Abd. Kakhar Umar, James H. Zothantluanga, Jittima Amie Luckanagul, Patanachai Limpikirati, Sriwidodo Sriwidodo. Structure-based computational screening of 470 natural quercetin derivatives for identification of SARS-CoV-2 M
pro
inhibitor. PeerJ 2023, 11 , e14915. https://doi.org/10.7717/peerj.14915
- Abd. Kakhar Umar, James H. Zothantluanga, Keerthic Aswin, Saipul Maulana, Muhammad Sulaiman Zubair, H. Lalhlenmawia, Mithun Rudrapal, Dipak Chetia. Antiviral phytocompounds “ellagic acid” and “(+)-sesamin” of Bridelia retusa identified as potential inhibitors of SARS-CoV-2 3CL pro using extensive molecular docking, molecular dynamics simulation studies, binding free energy calculations, and bioactivity prediction. Structural Chemistry 2022, 33
(5)
, 1445-1465. https://doi.org/10.1007/s11224-022-01959-3
- Asha Rani Choudhury, Atanu Maity, Sayantani Chakraborty, Rajarshi Chakrabarti. Computational design of stapled peptide inhibitor against
SARS‐CoV
‐2 receptor binding domain. Peptide Science 2022, 114
(5)
https://doi.org/10.1002/pep2.24267
- Susan Tzotzos. Stapled peptides as potential inhibitors of SARS‐CoV‐2 binding to the hACE2 receptor. Journal of Peptide Science 2022, 28
(9)
https://doi.org/10.1002/psc.3409
Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.
Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.
The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.